Delivery Order SPE2DB20D1100-SPE2DB25FD7D4
- Not listed
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Januvia 100 mg tablets in quantities of 1,000 units. The contract is valued at $12,163.38 and carries a firm fixed price structure with an ultimate completion date of August 1, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets (90-count units) at a ceiling value of $1,091.46. This firm fixed-price delivery order, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The product will be sourced from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 14, 2025, for the supply of Januvia 100 mg tablets (90-count) at a ceiling value of $1,273.37. This non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Januvia 100 mg tablets in quantities of 90 units, with a contract ceiling value of $2,211.60. This is a firm fixed-price delivery order with an ultimate completion date of August 13, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Januvia 100 mg tablets in a 90-count quantity. This competitively awarded, non-set-aside contract has a ceiling value of $1,420.02 and is classified as a firm fixed-price delivery order with an ultimate completion date of June 2, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Januvia 100 mg tablets (90-count packages) valued at $1,718.04. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of September 10, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item purchase under AmerisourceBergen's existing pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units) on September 9, 2025, with completion scheduled for September 10, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects a routine pharmaceutical procurement fulfilling military healthcare supply requirements. The work will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Januvia 100 mg tablets (90-count) with a contract value of $1,455.28. This firm fixed price delivery order, which completes on August 14, 2025, represents a non-set-aside competitive award supporting federal pharmaceutical procurement needs. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $1,637.19. The delivery order, which represents a child contract under a larger vehicle, carries an ultimate completion date of September 11, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This award was made through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Januvia 100 mg tablets (90-count units) under a firm fixed-price contract valued at $34,830.84. This non-set-aside, competitively awarded delivery order is scheduled for completion by September 9, 2025, with fulfillment from AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a specific pharmaceutical procurement supporting federal medical...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD7D4Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units) with a contract ceiling value of $10,113.96. This is a firm fixed price delivery order with no set-aside designation, indicating the award resulted from open competition. The place of performance is located at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of July 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime vendor agreement serves as a comprehensive pharmaceutical supply vehicle enabling AmerisourceBergen to deliver a broad range of medications and medical supplies to support military healthcare programs globally. The underlying IDC structure allows DLA to issue multiple delivery orders for various pharmaceutical products across different therapeutic domains to support Defense Health Agency operations and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.1k | 7/29/25 |